BioSpace News Archive

Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company, reiterated today what it had previously disclosed in 2021, that certain government agencies had requested information from the Company.

If you want to track a person’s activities for a day, you could call them up every ten minutes and ask what they’re doing.

Kåre Schultz, CEO of Teva, spoke at the Q2 earnings call of Teva: Answering questions from participants.

Innova Medical Group, Inc., a global health innovator and a world leader in the development and distribution of rapid diagnostic tests and other medical devices, announced today the appointment of Robert A. Kasprzak as the company’s Chief Executive Officer, following his role Chief Legal Officer since the company’s inception.

CARF International announced that Pacific Quest has been accredited for a period of three years for its adolescent and young adult programs.

Histogen Inc. announced that Histogen’s financial results for the second quarter ended June 30, 2022 will be released after the close of market on Thursday, August 11, 2022.

STRATA Skin Sciences, Inc. announced that it plans to release its second quarter 2022 financial results on Wednesday, August 10, 2022.

Oncocyte Corporation, a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey, announced that it will release its second quarter 2022 financial results on Wednesday, August 10, 2022.

Aligos Therapeutics, Inc. announced that it will report the company’s second quarter 2022 financial results on Thursday, August 4, 2022 after the close of the U.S. financial markets.

Terns Pharmaceuticals, Inc. announced the appointment of Radhika Tripuraneni, M.D., M.P.H. to the Company’s Board of Directors.